High Throughput Screening Market to Surge with 11.0% CAGR, Global Revenue to Exceed US$ 74.53 Billion by 2032

The use of automated systems and advanced software to efficiently manage & analyze large sample volumes is a key driver of the high-throughput screening market.

NEW YORK CITY, NY, UNITED STATES, January 13, 2025 /EINPresswire.com/ -- The high throughput screening market forecast for 2032 is a specialized study of the industry with a specific concentration on the global market trend analysis.

𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐫𝐞𝐜𝐞𝐧𝐭𝐥𝐲 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐭𝐬 𝐥𝐚𝐭𝐞𝐬𝐭 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐭𝐢𝐭𝐥𝐞𝐝 “𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭." 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐨𝐫 𝐡𝐢𝐠𝐡 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 29.40 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 74.53 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 11.0% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/high-throughput-screening-market/request-for-sample?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠?
High throughput screening is a drug detection procedure that permits mechanized testing of an extensive aggregate of chemicals and biological compounds for particular biological objectives, for instance, through binding assays. HTS practices are considerably utilized in the pharmaceutical industry, influencing robotics and automation to speedily examine the biological or biochemical venture of an extensive aggregate of molecules.

The essential objective of HTS is to recognize, through compound library screenings, contenders that influence the object in a craved way known as hits or leads. The growing existence of detrimental illnesses and the determined requirement for productive cures is impacting the high throughput screening market growth favourably.

𝐖𝐡𝐨 𝐌𝐚𝐤𝐞𝐬 𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠?
• Agilent TechnologiesInc.
• Aurora Biomed Inc.
• Axxam S.p.A.
• Biomat Srl
• Bio-Rad LaboratoriesInc.
• BMG Labtech GmbH
• Brand GmbH+Co KG
• and Charles River Laboratories

are some of the leading players in high throughput screening market. Spearheading market contenders are funding massively in research and development to augment their product lines which will assist the market to grow even more.

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:
• In May 2024, Twist Bioscience instigated Twist Multiplexed Gene Fragments (MGFs), sanctioning high throughput screening applications with reservoirs of instantly synthesized DNA specks up to 500 base pairs in length.
• In December 2023, Piramal Pharma augmented its drug detection potential with a contemporary high-throughput screening space in Ahmedabad, India, improving in vitro biology services for complete client reinforcement covering research and development.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/high-throughput-screening-market/request-for-discount-pricing?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐖𝐡𝐚𝐭’𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐰𝐚𝐫𝐝?
Continuing Progression in Robotics and Automation: Ongoing progression in robotics, automation, and software has also transformed high throughput screening (HTS) platforms, notably improving their productivity and potential. Mechanizing tedious chores such as sample managing, compound screening, and data analysis, contemporary HTS systems maximize workflows and speed up the estimation of substantial compound libraries.

Shift towards Customized Medicines: The market is driven by a shift towards customized medicines showcasing a changing perspective in healthcare targeting to customize medical cures to discrete patients dependent on their distinct genetic makeup, ecological submissions, and lifestyle elements. This, in turn, is having a favorable impact on high throughput screening market sales.

Technological Progressions: Technological progressions in assay advancement have transfigured high throughput screening (HTS), rendering a foundation in pharmaceuticals, biotechnology, and academic research. The compactness of assays permits researchers to carry out screening with decreased specimen and reagent proportions, notably lessening prices and escalating throughput.

𝐖𝐡𝐢𝐜𝐡 𝐑𝐞𝐠𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡?
North America: North America accounted for the largest high throughput screening market share. The region's robust growth is primarily due to a notable surge in research and development and funding by pharmaceutical and biotechnology firms for drug and biomarker advancements to confront the growing existence of detrimental illnesses such as cancer and cardiovascular conditions.

Asia Pacific: Asia Pacific is anticipated to witness significant growth from 2024 to 2032. This can be attributed to a varied patient population that seizes a broad gamut of therapeutics, thereby escalating the demand for distinct drug advancement.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/high-throughput-screening-market/inquire-before-buying?utm_source=EIN&utm_medium=EIN&utm_campaign=EIN&utm_id=01

𝐇𝐨𝐰 𝐈𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐃𝐨𝐧𝐞?
By Offering Outlook
• Consumables
o Reagents & Assay Kits
o Laboratory Consumables
• Instruments
o Liquid Handling Systems
o Detection Systems
o Imaging Systems
o Others
• Services
• Software

By Technology Outlook
• Cell-based Assays
o 2D Cell Culture
o 3D Cell Culture
 Scaffold-based Technology
 Hydrogels
• Animal-derived Hydrogels
 Matrigel
 Collagen
o Synthetic Hydrogels
o Alginate/Agarose
• Inert Matrix/Solid Scaffolds
• Micropatterned Surfaces
• Scaffold-free Technology
o Ultra-low Binding Plates
o Hanging-drop Plates
o Others
• Reporter-based Assays
• Perfusion Cell Culture
• Lab-on-a-Chip Technology (LOC)
• Label-free Technology

By Application Outlook
• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Others

By End User Outlook
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others

By Regional Outlook
• North America
o US
o Canada

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific

• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of the Middle East & Africa
• Latin America

o Mexico
o Brazil
o Argentina
o Rest of Latin America

𝐅𝐀𝐐𝐬:
How much is the high throughput screening market?
The market size was valued at USD 29.40 billion in 2023 and is anticipated to reach USD 74.53 billion in 2032.

What are the segments covered in the high throughput screening market?
The segments covered in the report are offerings, technology, application, end user, and region.

Which segment based on offering led the market in the forecast period?
The consumables segment led the market from 2024 to 2032.

What is the growth rate of the market?
The global market is projected to grow at a CAGR of 11.0% during the forecast period, 2024-2032.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐏𝐌𝐑'𝐬 𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐟𝐫𝐨𝐦 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐭𝐨 𝐒𝐮𝐫𝐩𝐚𝐬𝐬 𝐔𝐒𝐃 74.53 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032, 𝐖𝐢𝐭𝐡 11.0% 𝐂𝐀𝐆𝐑 | 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Digestive & Intestinal Remedies Market:
https://www.polarismarketresearch.com/industry-analysis/digestive-and-intestinal-remedies-market

Non-alcoholic Steatohepatitis Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/non-alcoholic-steatohepatitis-treatment-market

Paracetamol IV Market:
https://www.polarismarketresearch.com/industry-analysis/paracetamol-iv-market

Personalized Medicine Biomarkers Market:
https://www.polarismarketresearch.com/industry-analysis/personalized-medicine-biomarkers-market

Medical Device Engineering Market:
https://www.polarismarketresearch.com/industry-analysis/medical-device-engineering-market

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn